In this 2001 clinical trial, Gupta and his colleagues studied the effects of gum resin of Boswellia serrata in patients with chronic colitis. Thirty patients, 17 males and 13 females in the age range of 18 to 48 years with chronic colitis were included in this study. Twenty patients were given a preparation of the …
Effects of gum resin of Boswellia serrata in patients with chronic colitis. Read More »
This 2015 preclinical paper examines the pharmacological mechanisms mediated by BSE, in protecting intestinal epithelial barrier from inflammatory damage and supports its use as a safe adjuvant in patients affected by IBD. Fortification of the intestinal barrier function is still a challenge in acute or chronic colonic cell lines and supplementation with Boswellia demonstrated key …
This comprehensive review published in 2021 evaluated evidence relating to the clinical use of exogenous supplemental bovine colostrum in human health. 24 full text studies were selected and reviewed regarding intestinal and respiratory recovery. The mechanism of action seemed to suggest bovine colostrum modulates the immune response and may increase sIgA. References: Guberti, M., Botti, …
Bovine colostrum applications in sick and healthy people: A systematic review Read More »
This comprehensive review published in 2021 in Nutrients, reviews the main constituents, quality control and an overview of the use of bovine colostrum in health and disease. Bovine colostrum active constituents include immunoglobulins, cytokines, oligosaccharides and immune factors. It also contains growth factors and hormones which account for many of the health benefits. Multiple studies …
The prestigious scientific journal Nutrients published this special edition in 2022 for a comprehensive review of the health potential of bovine colostrum supplementation. Including five review articles, use in gastrointestinal health and disease, sports nutrition, pediatrics, and immune support. It also includes a systematic review of its clinical use and an original research article examining …
The aim of this study was to assess the clinical effect of α-galactosidase. Following supplementation, participants were assessed for severe clinical events, renal function and cardiac structure. This 10-year study documents the effectiveness of agalsidase beta (1 mg/kg/2 weeks) in patients with Fabry disease. Most patients remained alive and event-free. Patients who initiated treatment at a younger …
In 2022 this review article provided a complete assessment of the preparations for effective alpha galactosidase preparations in order to relieve postprandial symptoms of discomfort. Highlighting the efficacy of algae sources such as Aspergillus niger. References: Anisha G. S. (2023). Biopharmaceutical applications of α-galactosidases. Biotechnology and applied biochemistry, 70(1), 257–267. https://doi.org/10.1002/bab.2349
From 2016, this randomized controlled clinical trial, included patients with dyspepsia from peptic ulcer disease or non-ulcer dyspepsia and a positive rapid urease test (which is used to detect H pylori). The group given DGL showed significantly greater therapeutic response (negative H pylori test) compared to the control group (83.8% vs 62.5%, respectively). References: Hajiaghamohammadi …
In an in vitro study, DGL was effective at inhibiting a strain of Streptococcus mutans and preventing biofilm formation. Researchers suggest that the antimicrobial effects of DGL on S. mutans could lead to the development of DGL oral hygiene products. References: Ahn S-J, Cho E-J, Kim H-J, et al. (2012). The antimicrobial effects of deglycyrrhizinated …
This prospective, randomized, double-blind, placebo-controlled trial from 2019 included 46 participants with active mild to moderate ulcerative colitis. Results found 2000 mg/day ginger supplementation can “improve disease severity index and oxidative stress.” Further symptoms such as intestinal gas, bloating and abdominal pain decreased after taking ginger. References: Nikkhah-Bodaghi M, Maleki I, Agah S, Hekmatdoost A. …
